Results 131 to 140 of about 715,175 (219)

40 | Predictive accuracy of anticholinergic burden scales for ecg abnormalities in older adults

Geriatric Care
Introduction. Polypharmacy and anticholinergic burden (AB) are common in older adults, but their impact on cardiac electrophysiology remains unclear. Objectives.
Segreteria SIGOT
doaj  

Prevalence of Psychotropic Use and Psychotropic Polypharmacy in a Finnish National Cohort of Persons With Intellectual Disabilities

Journal of Intellectual Disability Research, Volume 70, Issue 10, Page 1112-1124, October 2026.
ABSTRACT Background Psychotropic use and psychotropic polypharmacy are common in people with intellectual disabilities, but representative population‐based studies on this topic are scarce. We evaluated the prevalence of psychotropic use and psychotropic polypharmacy in a Finnish nationwide cohort of people with intellectual disabilities aged 0–97 ...
Ville Virtanen, Leena Saastamoinen, Maria Arvio, Hannu T. Vesala, Sonja Miettinen, Antti Teittinen, Anna‐Maija Tolppanen   +6 more
wiley   +1 more source

CALS and ACB Scales are Associated with Physical and Cognitive Impairment and Predict Mortality in Nursing Home Residents

Drugs - Real World Outcomes
Background and Objective Anticholinergic medications are known to affect the prognosis of older nursing home residents. Various anticholinergic scales were developed to measure the cumulative anticholinergic burden; among them, the CRIDECO ...
Luca Soraci, Ersilia Paparazzo, Mirella Aurora Aceto, Francesco Bruno, Teresa Serra Cassano, Davide Lagrotteria, Salvatore Claudio Cosimo, Pierluigi Mercatante, Francesco Morelli, Maria Princiotto, Andrea Corsonello, Giuseppe Passarino, Alberto Montesanto   +12 more
doaj   +1 more source

Longitudinal relations among anticholinergic drug burden, neurocognition, and community functioning in outpatients with serious mental illness

, 2017
The present study is the first to examine the links among anticholinergic drug burden, neurocognition, and community functioning in outpatients with serious mental illness (SMI).
Bouchard, Axel Benjamin
core  

Anticholinergic Burden in Individuals with Down Syndrome: An Examination of Risk and Clinical Implications. [PDF]

J Pers Med
Villani ER, Liperoti R, Franza L, Secciani FM, Di Paola A, Onder G, Carfì A.   +6 more
europepmc   +1 more source

Cumulative Anticholinergic Burden and Risk of Delirium Among Older Adults with Alzheimer's Disease. [PDF]

Pharmacy (Basel)
Talwar A, Sherer J, Abughosh S, Chatterjee S, Aparasu RR.   +4 more
europepmc   +1 more source

The Association Between Anticholinergic Burden and Treatment-Related Complications in Older Adults with Cancer. [PDF]

Drugs Aging
Brokaar EJ, Trompet S, Portielje JEA, Visser LE, Mooijaart SP, Uit den Boogaard A, Baltussen JC, van Holstein Y, van den Bos F.   +8 more
europepmc   +1 more source

The Feasibility and Acceptability of a Collaborative Deprescribing Intervention to Reduce Anticholinergic Burden Among Hospitalised Older Patients. [PDF]

Basic Clin Pharmacol Toxicol
Ibrahim K, Radcliffe E, Hewertson E, Bates A, Fox A, Smith E, Mckenzie C, Jones L, Mckelvie S, Kandala NI, McCloskey S, Sach T, Lim S.   +12 more
europepmc   +1 more source

Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults - results from the ActiFE study. [PDF]

Eur J Clin Pharmacol
Lorenz L, Berres J, Denkinger MD, Rothenbacher D, Braig S, Dallmeier D, Just KS.   +6 more
europepmc   +1 more source

Response to "Comment on cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults - results from the ActiFE study". [PDF]

Eur J Clin Pharmacol
Lorenz L, Berres J, Denkinger MD, Rothenbacher D, Braig S, Dallmeier D, Just KS.   +6 more
europepmc   +1 more source